Although pharmaceutical marketing has long played an important role in the dissemination of information to physicians in all specialties, the opioid crisis has cast a new—and potentially troubling—light on the practice. According to a recent analysis by a multicenter research team, such marketing may actually be associated with higher mortality from opioid-related overdoses.
However, the results prompted clinical pain experts to question the study’s methodology while